Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
3mg
Package
Savings
Per tablet
Price
Order
90 tablets
kr 2981.03
kr 99.45
kr 8950.71
Free AirMail shipping
60 tablets
kr 1589.64
kr 106.08
kr 6364.85
Free AirMail shipping
30 tablets
kr 596.07
kr 112.71
kr 3381.17
Free AirMail shipping
20 tablets
kr 264.88
kr 119.33
kr 2386.61
Free AirMail shipping
10 tablets
kr 132.57
kr 1325.75
Free AirMail shipping
7mg
Package
Savings
Per tablet
Price
Order
90 tablets
kr 1190.82
kr 119.34
kr 10740.92
Free AirMail shipping
60 tablets
kr 595.08
kr 122.66
kr 7359.41
Free AirMail shipping
30 tablets
kr 198.25
kr 125.97
kr 3779.00
Free AirMail shipping
20 tablets
kr 65.97
kr 129.28
kr 2585.52
Free AirMail shipping
10 tablets
kr 132.57
kr 1325.75
Free AirMail shipping
14mg
Package
Savings
Per tablet
Price
Order
90 tablets
kr 1489.19
kr 142.55
kr 12829.49
Free AirMail shipping
60 tablets
kr 793.99
kr 145.86
kr 8751.80
Free AirMail shipping
30 tablets
kr 297.70
kr 149.17
kr 4475.19
Free AirMail shipping
20 tablets
kr 132.28
kr 152.48
kr 3049.65
Free AirMail shipping
10 tablets
kr 159.10
kr 1590.96
Free AirMail shipping
Rybelsus® tablets
What is Rybelsus?
Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.
Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.
Warnings
You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.